The TabNet model predicted doxorubicin-induced cardiotoxicity with an AUC of 0.86 and C-index of 0.80, outperforming other predictive algorithms.
Does a TabNet-based multidimensional deep learning model accurately predict doxorubicin-induced cardiotoxicity in breast cancer patients compared to other machine learning algorithms?
A TabNet-based deep learning model accurately and interpretably predicts doxorubicin-induced cardiotoxicity in breast cancer patients, outperforming traditional machine learning algorithms.
Absolute Event Rate: 0% vs 0%
Objective: To develop and validate an interpretable deep learning model based on the TabNet architecture for predicting doxorubicin-induced cardiotoxicity (DIC) in patients with breast cancer through integration of multidimensional clinical data. Methods: This retrospective study included 2034 patients who received doxorubicin-based chemotherapy at The Fourth Affiliated Hospital of Harbin Medical University between January 2021 and December 2023. Clinical, biochemical, electrocardiographic, and echocardiographic parameters were incorporated into six predictive algorithms: logistic regression, decision tree, random forest, gradient boosting machine, XGBoost, and TabNet. Model discrimination, calibration, and clinical utility were assessed using AUC, C-index, calibration plots, and decision curve analysis. Model interpretability was evaluated through attention-based feature importance and SHAP analysis. Results: TabNet achieved the best overall predictive performance, with an AUC of 0.86 and a C-index of 0.80 in the validation cohort, demonstrating superior discrimination, calibration, and generalization compared with all baseline models. Decision curve analysis confirmed its higher net clinical benefit across threshold probabilities. The model identified eight dominant predictors—cumulative anthracycline dose, LVEF, QTc interval, lactate dehydrogenase, creatinine, glucose, hypertension, and platelet count—that collectively reflected myocardial contractility, electrophysiological stability, and systemic metabolic stress. Correlation and clustering analyses revealed that high-risk patients exhibited concurrent QTc prolongation, metabolic disturbance, and LVEF decline, defining a distinct cardiometabolic injury phenotype. These findings highlight TabNet’s ability to uncover complex feature interactions while maintaining transparent and clinically interpretable outputs. Conclusions: The TabNet-based multidimensional model provides an accurate, stable, and interpretable tool for individualized prediction of doxorubicin-induced cardiotoxicity, supporting early intervention and precision management in breast cancer patients receiving anthracycline therapy.
Cao et al. (Tue,) reported a other. The TabNet model predicted doxorubicin-induced cardiotoxicity with an AUC of 0.86 and C-index of 0.80, outperforming other predictive algorithms.